Long-term outcomes of intravascular ultrasound-guided drug-eluting stents implantation in patients with acute coronary syndrome: ULTIMATE ACS subgroup
高晓飞 1韩冷 2钱雪松 3葛震 1孔祥权 1陆曙 4阚静 1左广锋 1张俊杰 1陈绍良 1范姝婕
扫码查看
点击上方二维码区域，可以放大扫码查看
作者信息
1. 南京医科大学附属南京医院 南京市第一医院心内科，南京 210006
2. 常熟市第一人民医院心内科，常熟 215500
3. 张家港市第一人民医院心内科，张家港 215600
4. 太仓市第一人民医院心内科，太仓 215400
折叠
摘要
目的 评估血管内超声（IVUS）指导药物洗脱支架（DES）置入对急性冠脉综合征（ACS）患者长期临床结局的影响。 方法 研究对象来源于ULTIMATE研究，该研究是一项前瞻性、多中心、随机对照研究，于2014年8月—2017年5月在国内8家医院入选1 448例置入DES的冠心病患者。本研究为ULTIMATE研究的亚组分析，将冠心病患者分为ACS组和非ACS组，2组患者均在IVUS或冠状动脉造影指导下置入DES。主要终点是术后3年靶血管失败（TVF）率，包含心原性死亡、靶血管心肌梗死和临床驱动的靶血管血运重建。 结果 1 448例冠心病患者中，ACS组1 136例（78.5%），1 423例（98.3%）患者完成术后3年随访。ACS组患者术后3年的TVF发生率为9.6%（109/1 136），高于非ACS组的4.5%（14/312），log-rank P=0.005。ACS组中IVUS指导下置入DES者的TVF发生率低于冠状动脉造影指导下置入DES架者［7.6%（43/569）比11.6%（66/567），log-rank P=0.019］。ACS组中IVUS指导下DES置入达标组患者术后3年的TVF发生率为5.4%（16/296），低于IVUS未达标组的9.9%（27/273），log-rank P=0.041。 结论 ACS患者置入DES后3年的TVF事件率高于无ACS患者；相比于冠状动脉造影，IVUS指导DES置入可以降低ACS患者术后3年的TVF事件，尤其是IVUS指导下DES置入达标的患者获益更明显。 Objective To explore the long-term effects of intravascular ultrasound (IVUS) guidance on patients with acute coronary syndrome (ACS) undergoing drug-eluting stents (DES) implantation. Methods Data used in this study derived from ULTIMATE trial, which was a prospective, multicenter, randomized study. A total of 1 448 all-comer patients were enrolled between 2014 August and 2017 May. Primary endpoint of this study was target vessel failure (TVF) at 3 years, including cardiac death, target-vessel-related myocardial infarction, and clinically-driven target vessel revascularization. Results ACS was present in 1 136 (78.5%) patients, and 3-year clinical follow-up was available in 1 423 patients (98.3%). TVF in the ACS group was 9.6% (109/1 136), which was significantly higher than 4.5% (14/312) in the non-ACS group (log-rank P=0.005). There were 109 TVFs in the ACS patients, with 7.6% (43/569) TVFs in the IVUS group and 11.6% (66/567) TVFs in the angiography group (log-rank P=0.019). Moreover, patients with optimal IVUS guidance were associated with a lower risk of 3-year TVF compared to those with suboptimal IVUS results (5.4% (16/296) vs. 9.9% (27/273),log-rank P=0.041). Conclusions This ULTIMATE-ACS subgroup analysis showed that ACS patients undergoing DES implantation were associated with a higher risk of 3-year TVF. More importantly, the risk of TVF could be significantly decreased through IVUS guidance in patients with ACS, especially in those who had an IVUS-defined optimal procedure.
Abstract
Objective To explore the long-term effects of intravascular ultrasound (IVUS) guidance on patients with acute coronary syndrome (ACS) undergoing drug-eluting stents (DES) implantation. Methods Data used in this study derived from ULTIMATE trial, which was a prospective, multicenter, randomized study. A total of 1 448 all-comer patients were enrolled between 2014 August and 2017 May. Primary endpoint of this study was target vessel failure (TVF) at 3 years, including cardiac death, target-vessel-related myocardial infarction, and clinically-driven target vessel revascularization. Results ACS was present in 1 136 (78.5%) patients, and 3-year clinical follow-up was available in 1 423 patients (98.3%). TVF in the ACS group was 9.6% (109/1 136), which was significantly higher than 4.5% (14/312) in the non-ACS group (log-rank P=0.005). There were 109 TVFs in the ACS patients, with 7.6% (43/569) TVFs in the IVUS group and 11.6% (66/567) TVFs in the angiography group (log-rank P=0.019). Moreover, patients with optimal IVUS guidance were associated with a lower risk of 3-year TVF compared to those with suboptimal IVUS results (5.4% (16/296) vs. 9.9% (27/273),log-rank P=0.041). Conclusions This ULTIMATE-ACS subgroup analysis showed that ACS patients undergoing DES implantation were associated with a higher risk of 3-year TVF. More importantly, the risk of TVF could be significantly decreased through IVUS guidance in patients with ACS, especially in those who had an IVUS-defined optimal procedure.
万方数据